0LB2 fundamentals
An in-depth look to SUPERNUS PHARMACEUTICALS INC USD0.001 operating, investing, and financing activities
0LB2 free cash flow for Q1 24 is 38.15 M USD. For 2023, 0LB2 free cash flow was 110.53 M USD and operating cash flow was 111.08 M USD.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM